Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats

Tetsuya Oishi, Toshio Ogura, Takayoshi Yamauchi, Kazushi Harada, Zensuke Ota

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

To determine whether growth factors in the glomerulus are induced hi the renin-suppressed hypertensive model, we examined the mRNA expressions of platelet-derived growth factor (PDGF) B-chain, transforming growth factor (TGF)-β1 and angiotensin II type 1 (AT1) receptors in the glomeruli of deoxycorticosterone acetate (DOCA)-salt-treated hypertensive rats (DOCA-treated rats). We also examined the effects of treatment with cilazapril, an angiotensin I-converting enzyme inhibitor (ACEI), and L-158,809, an AT1 receptor antagonist, on these expressions in DOCA-treated rats. We administered oral 10 mg/kg of cilazapril (CILAZA group) and 1 mg/kg of L-158,809 (L158 group) to DOCA-treated rats daily. Systolic blood pressure in the two groups was not decreased compared with that in DOCA-treated rats given saline. The mRNA expressions were examined using reverse transcriptase polymerase chain reaction (RT-PCR) methods. The mRNA expressions of these genes were higher in DOCA-treated rats than in age-matched control rats. After treatment with these agents for 4 weeks, the mRNA expressions of growth factors were Suppressed in both the CILAZA and L158 groups. Mesangial expansion and cell proliferation observed in DOCA-treated rats were suppressed in both the CILAZA and L158 groups. Decreases in the size of the glomerulus were observed only in the CILAZA group. These findings suggested that suppression of growth factors and glomerular proliferative changes of these agents are mediated by blocking tissue renin-angiotensin system (RAS) in the renin-suppressed model.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalRegulatory Peptides
Volume62
Issue number2-3
DOIs
Publication statusPublished - Apr 23 1996

Fingerprint

Desoxycorticosterone
Angiotensins
Renin
Rats
Acetates
Salts
Wounds and Injuries
Cilazapril
Intercellular Signaling Peptides and Proteins
Messenger RNA
Rat control
Proto-Oncogene Proteins c-sis
Angiotensin II Type 1 Receptor Blockers
Angiotensin Type 1 Receptor
Blood Pressure
Polymerase chain reaction
RNA-Directed DNA Polymerase
Blood pressure
Cell proliferation
Transforming Growth Factors

Keywords

  • Angiotensin II receptor antagonist
  • Angiotensin-I-converting enzyme inhibitor
  • DOCA-salt hypertensive rat
  • Glomerulus
  • Growth fctor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. / Oishi, Tetsuya; Ogura, Toshio; Yamauchi, Takayoshi; Harada, Kazushi; Ota, Zensuke.

In: Regulatory Peptides, Vol. 62, No. 2-3, 23.04.1996, p. 89-95.

Research output: Contribution to journalArticle

Oishi, Tetsuya ; Ogura, Toshio ; Yamauchi, Takayoshi ; Harada, Kazushi ; Ota, Zensuke. / Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. In: Regulatory Peptides. 1996 ; Vol. 62, No. 2-3. pp. 89-95.
@article{041c6e1341b44e108d41209f9f606469,
title = "Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats",
abstract = "To determine whether growth factors in the glomerulus are induced hi the renin-suppressed hypertensive model, we examined the mRNA expressions of platelet-derived growth factor (PDGF) B-chain, transforming growth factor (TGF)-β1 and angiotensin II type 1 (AT1) receptors in the glomeruli of deoxycorticosterone acetate (DOCA)-salt-treated hypertensive rats (DOCA-treated rats). We also examined the effects of treatment with cilazapril, an angiotensin I-converting enzyme inhibitor (ACEI), and L-158,809, an AT1 receptor antagonist, on these expressions in DOCA-treated rats. We administered oral 10 mg/kg of cilazapril (CILAZA group) and 1 mg/kg of L-158,809 (L158 group) to DOCA-treated rats daily. Systolic blood pressure in the two groups was not decreased compared with that in DOCA-treated rats given saline. The mRNA expressions were examined using reverse transcriptase polymerase chain reaction (RT-PCR) methods. The mRNA expressions of these genes were higher in DOCA-treated rats than in age-matched control rats. After treatment with these agents for 4 weeks, the mRNA expressions of growth factors were Suppressed in both the CILAZA and L158 groups. Mesangial expansion and cell proliferation observed in DOCA-treated rats were suppressed in both the CILAZA and L158 groups. Decreases in the size of the glomerulus were observed only in the CILAZA group. These findings suggested that suppression of growth factors and glomerular proliferative changes of these agents are mediated by blocking tissue renin-angiotensin system (RAS) in the renin-suppressed model.",
keywords = "Angiotensin II receptor antagonist, Angiotensin-I-converting enzyme inhibitor, DOCA-salt hypertensive rat, Glomerulus, Growth fctor",
author = "Tetsuya Oishi and Toshio Ogura and Takayoshi Yamauchi and Kazushi Harada and Zensuke Ota",
year = "1996",
month = "4",
day = "23",
doi = "10.1016/0167-0115(95)00166-2",
language = "English",
volume = "62",
pages = "89--95",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats

AU - Oishi, Tetsuya

AU - Ogura, Toshio

AU - Yamauchi, Takayoshi

AU - Harada, Kazushi

AU - Ota, Zensuke

PY - 1996/4/23

Y1 - 1996/4/23

N2 - To determine whether growth factors in the glomerulus are induced hi the renin-suppressed hypertensive model, we examined the mRNA expressions of platelet-derived growth factor (PDGF) B-chain, transforming growth factor (TGF)-β1 and angiotensin II type 1 (AT1) receptors in the glomeruli of deoxycorticosterone acetate (DOCA)-salt-treated hypertensive rats (DOCA-treated rats). We also examined the effects of treatment with cilazapril, an angiotensin I-converting enzyme inhibitor (ACEI), and L-158,809, an AT1 receptor antagonist, on these expressions in DOCA-treated rats. We administered oral 10 mg/kg of cilazapril (CILAZA group) and 1 mg/kg of L-158,809 (L158 group) to DOCA-treated rats daily. Systolic blood pressure in the two groups was not decreased compared with that in DOCA-treated rats given saline. The mRNA expressions were examined using reverse transcriptase polymerase chain reaction (RT-PCR) methods. The mRNA expressions of these genes were higher in DOCA-treated rats than in age-matched control rats. After treatment with these agents for 4 weeks, the mRNA expressions of growth factors were Suppressed in both the CILAZA and L158 groups. Mesangial expansion and cell proliferation observed in DOCA-treated rats were suppressed in both the CILAZA and L158 groups. Decreases in the size of the glomerulus were observed only in the CILAZA group. These findings suggested that suppression of growth factors and glomerular proliferative changes of these agents are mediated by blocking tissue renin-angiotensin system (RAS) in the renin-suppressed model.

AB - To determine whether growth factors in the glomerulus are induced hi the renin-suppressed hypertensive model, we examined the mRNA expressions of platelet-derived growth factor (PDGF) B-chain, transforming growth factor (TGF)-β1 and angiotensin II type 1 (AT1) receptors in the glomeruli of deoxycorticosterone acetate (DOCA)-salt-treated hypertensive rats (DOCA-treated rats). We also examined the effects of treatment with cilazapril, an angiotensin I-converting enzyme inhibitor (ACEI), and L-158,809, an AT1 receptor antagonist, on these expressions in DOCA-treated rats. We administered oral 10 mg/kg of cilazapril (CILAZA group) and 1 mg/kg of L-158,809 (L158 group) to DOCA-treated rats daily. Systolic blood pressure in the two groups was not decreased compared with that in DOCA-treated rats given saline. The mRNA expressions were examined using reverse transcriptase polymerase chain reaction (RT-PCR) methods. The mRNA expressions of these genes were higher in DOCA-treated rats than in age-matched control rats. After treatment with these agents for 4 weeks, the mRNA expressions of growth factors were Suppressed in both the CILAZA and L158 groups. Mesangial expansion and cell proliferation observed in DOCA-treated rats were suppressed in both the CILAZA and L158 groups. Decreases in the size of the glomerulus were observed only in the CILAZA group. These findings suggested that suppression of growth factors and glomerular proliferative changes of these agents are mediated by blocking tissue renin-angiotensin system (RAS) in the renin-suppressed model.

KW - Angiotensin II receptor antagonist

KW - Angiotensin-I-converting enzyme inhibitor

KW - DOCA-salt hypertensive rat

KW - Glomerulus

KW - Growth fctor

UR - http://www.scopus.com/inward/record.url?scp=0029950620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029950620&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(95)00166-2

DO - 10.1016/0167-0115(95)00166-2

M3 - Article

VL - 62

SP - 89

EP - 95

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2-3

ER -